Complete clearance and psoriasis area and severity index response for brodalumab and ustekinumab in AMAGINE‐2 and ‐3-Reference-Cited by-同舟云学术

Complete clearance and psoriasis area and severity index response for brodalumab and ustekinumab in AMAGINE‐2 and ‐3

Published:2020-08-26 Issue:2 Volume:35 Page:450-457
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Warren R.B.¹,Hansen J.B.²,Reich K.³^ORCID,Paul C.⁴,Puig L.⁵^ORCID

Affiliation:

1. Dermatology Centre The University of Manchester Salford Royal NHS Foundation Trust NIHR Manchester BRC CentreManchester UK

2. LEO Pharma Ballerup Denmark

3. Institute for Health Services Research in Dermatology and Nursing University Medical Center Hamburg‐Eppendorf Skinflammation® Center Hamburg Germany

4. Toulouse University and Larrey Hospital Toulouse France

5. Department of Dermatology Hospital de la Santa Creu i Sant Pau Universitat Autònoma de Barcelona School of Medicine Barcelona Spain

Funder

Amgen

AstraZeneca

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.16816

Reference40 articles.

1. Genetic Epidemiology of Psoriasis

2. Guidelines of care for the management of psoriasis and psoriatic arthritis

3. The global burden of psoriatic skin disease

4. Biologics and Psoriasis

5. Psoriasis pathogenesis and the development of novel targeted immune therapies

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progression of Quality of Life in Patients with Plaque Psoriasis Who Achieved Three or More Years of Complete Skin Clearance with Guselkumab Treatment: a Post hoc Analysis of the VOYAGE 1 Clinical Trial;Dermatology and Therapy;2024-08-17

2. Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials;Journal of Dermatological Treatment;2024-06-30

3. Real-world outcomes and drug survival of brodalumab: results from the German Psoriasis Registry PsoBest;Journal of Dermatological Treatment;2024-04-18

4. Real‐world data on the effectiveness of brodalumab in patients with moderate‐to severe plaque psoriasis in the Greek clinical setting (the BrIDGE study);Journal of the European Academy of Dermatology and Venereology;2024-02-03

5. Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement;Journal of Clinical Medicine;2023-05-18